News
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
UnitedHealth shares dropped 55%, facing lawsuits and claim rejection issues. Management changes raise questions on recovery.
UnitedHealth’s stock cuts the Dow’s price by more than 400 points, as care activity accelerates and Medicare costs remain ...
UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results